02 / Research topics
Potential PhD Research Topics in Cancer Prevention
Explore suggested topics and the methods, tools and expertise that could support each investigation.
1
Multiomics guided precision prevention for individuals at inherited cancer risk
Distinguishing who will develop cancer among genetically predisposed individuals remains difficult because inherited variants interact with immune, metabolic, environmental, and behavioral factors. This project would integrate genomics, epigenomics, proteomics, and longitudinal exposures to construct and validate individualized prevention scores. Novelty lies in linking molecular risk profiles to actionable interventions rather than prediction alone. Objectives should include discovery, external validation, clinical utility assessment, and evaluation of psychological and equity consequences.
Applications and use cases
2
AI enabled prediction of modifiable cancer risk from longitudinal health data
Integrating fragmented electronic health records, wearable data, lifestyle measures, and socioeconomic information could improve prevention targeting, yet existing models often lack fairness, interpretability, and prospective validation. The proposed research should develop a clinically interpretable model for dynamic risk estimation and intervention timing. Its contribution would be a validated, bias-audited system that supports shared decision-making. Objectives include model development, subgroup fairness testing, prospective evaluation, and implementation analysis across healthcare settings.
Applications and use cases
3
Microbiome targeted interventions for prevention of inflammation driven gastrointestinal cancers
Decoding how gut microbial communities influence chronic inflammation, carcinogen metabolism, and immune surveillance may reveal preventable pathways in colorectal and other gastrointestinal cancers. Current studies are frequently cross-sectional, geographically narrow, and inconsistent in defining beneficial microbial changes. This proposal could combine longitudinal sampling with mechanistic experiments and a pilot dietary or microbial intervention. Objectives should establish causal signatures, identify responders, and determine whether microbiome modification produces durable reductions in inflammatory and precancerous biomarkers.
Applications and use cases
4
Therapeutic vaccines and immune priming for high risk precancerous lesions
Developing effective immunoprevention for precancerous lesions is challenging because immune responses may be weak, heterogeneous, or poorly sustained. This project would evaluate vaccines targeting tumor-associated or viral antigens in individuals with measurable precancerous disease. Novelty could come from combining antigen selection with immune profiling and rational adjuvants. Objectives should identify predictive immune signatures, optimize dosing, assess lesion regression, and establish safety, feasibility, and long-term prevention outcomes.
Applications and use cases
5
Exposome based discovery of preventable environmental causes across cancer types
Evaluating cumulative exposure to air pollution, chemicals, occupational hazards, climate stressors, and social conditions remains limited by fragmented measurement and latency between exposure and cancer. This research should create an exposome framework combining personal monitoring, geospatial data, biomarkers, and cancer registries. Novelty lies in identifying mixtures and interaction effects rather than isolated agents. Objectives include exposure reconstruction, causal mixture analysis, vulnerable subgroup identification, and translation into regulatory or individual prevention strategies.
Applications and use cases
6
Metabolic precision interventions for obesity associated cancer prevention
Engineering effective strategies against obesity-related cancers requires understanding why metabolic interventions work for some people but not others. Existing evidence often emphasizes weight loss while underexamining insulin resistance, adipose inflammation, sex differences, and cancer-specific mechanisms. This project could compare dietary, physical activity, pharmacological, and combination interventions using molecular and clinical endpoints. Objectives should identify responders, clarify biological mediators, test durability, and assess affordability and accessibility in diverse populations.
Applications and use cases
7
Equitable implementation of HPV vaccination and cervical cancer elimination strategies
Reimagining HPV prevention requires addressing persistent gaps in vaccine uptake, completion, trust, access, and screening among marginalized communities. Many interventions demonstrate efficacy but fail during real-world scale-up or overlook gender, migration, disability, and rural barriers. This proposal should co-design and evaluate a multilevel implementation strategy with communities, providers, and policymakers. Objectives include identifying contextual mechanisms, testing adaptive delivery models, measuring equity outcomes, and estimating population-level impact.
Applications and use cases
8
Repurposed chemoprevention agents guided by precancer molecular biomarkers
Testing existing drugs for chemoprevention can accelerate translation, but trials frequently expose low-risk populations to toxicity without reliable markers of benefit. This project should identify molecularly defined precancer subgroups most likely to respond to repurposed agents such as aspirin, statins, metformin, or anti-inflammatory therapies. Novelty would involve adaptive biomarker-guided prevention trials. Objectives include target validation, dose optimization, response prediction, toxicity monitoring, and evaluation of clinically meaningful lesion reduction.
Applications and use cases
9
Digital behavior change interventions for sustained tobacco and alcohol risk reduction
Testing scalable digital prevention programs is important because tobacco and alcohol remain major causes of avoidable cancer, while relapse and co-use undermine existing interventions. Current applications often lack personalization, objective exposure measurement, and long-term follow-up. This research could develop an adaptive intervention that combines just-in-time support, behavioral incentives, and risk communication. Objectives should optimize intervention components, evaluate cessation and reduction outcomes, examine equity, and quantify downstream cancer prevention potential.
Applications and use cases
10
Early interception of carcinogenesis using circulating cell free DNA signatures
Modeling molecular changes before clinical cancer could enable prevention trials and targeted surveillance, but circulating DNA signals may reflect benign conditions, clonal hematopoiesis, or technical artifacts. This proposal should develop a highly specific assay for detecting persistent precancer-associated changes and test whether it improves risk classification beyond conventional factors. Objectives include assay refinement, biological specificity testing, longitudinal validation, and evaluation of whether molecular feedback safely guides preventive interventions.
Applications and use cases